Insight Molecular Diagnostics Inc. Logo

Insight Molecular Diagnostics Inc. (7OC0)

Munich

Currency in EUR
2.78
0.00 (0.00%)

Closed

Oct 8, 2026

Day's Range

2.78
2.78

52 wk Range

2.78
2.78

Overview - 7OC0 - Insight Molecular Diagnostics Inc.

Key Statistics

Valuation

Enterprise Value

66.57M

P/E (Trailing)

‪-1.68‬

PEG Ratio

‪-0.50‬

Price / Sales (TTM)

‪54.47‬

Price / Book

‪-4.79‬

EV / EBITDA

‪-2.19‬

Profitability

Gross Margin

‪65.69%‬

Profit Margin

‪56.67%‬

Operating Margin

‪-3,815.06%‬

Return on Assets

‪-57.82%‬

Return on Equity

‪159.61%‬

Ownership

Shares Outstanding

32.62M

Float

10.40M

Held by Insiders

‪20.99%‬

Held by Institutions

‪56.42%‬

Price stats

Beta

‪1.80‬

50-Day Avg

‪2.78‬

200-Day Avg

‪2.78‬

Dividends

Payout Ratio

‪0.00%‬

News Teaser - 7OC0 - Insight Molecular Diagnostics Inc.

News & Analysis

View all news

Market Cap - 7OC0 - Insight Molecular Diagnostics Inc.

Peers - 7OC0 - Insight Molecular Diagnostics Inc.

Peer Comparison

Compared with companies in Diagnostics & Research listed on Munich.

Profile Summary - 7OC0 - Insight Molecular Diagnostics Inc.

About

Insight Molecular Diagnostics Inc. is a molecular diagnostics company focused on precision testing for transplantation and oncology. The company develops and commercializes laboratory-developed, kitted research-use, and clinical diagnostic tests that help clinicians assess organ rejection, monitor therapeutic…

SectorHealthcare
IndustryDiagnostics & Research
Employees55
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.